Praxis Precision Medicines (PRAX) Financials: Revenue & Earnings
PRAX$278.63+11.04 +4.12%
$7.78B
Market Cap
-20.65
P/E
51.97
Forward P/E
65
Score
Praxis Precision Medicines (PRAX) Financials: Revenue & Earnings
PRAX price $278.63 +11.04 +4.12%
- Ticker
- PRAX
- Price
- $278.63
- Change
- +11.04 +4.12%
- Market cap ?
- $7.78B
- P/E ?
- -20.65
- Forward P/E ?
- 51.97
- Dividend yield ?
- 0.00%
- Beta ?
- 2.81
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
- Value
- 48
- Quality
- 48
- Growth
- 100
Stocklytics score rationale: value 48, quality 48, growth 100.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 2447000 | 8553000 | 0 |
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which…
Fair value
PRAX fair value $113.09. Price $278.63. Price is 146% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.81M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 27.92M. Net debt -357.22M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -3.54 | — | 130.77K |
| 2026-08-06 | -2.87 | -3.67 | — | 1.25M |
| 2026-05-07 | -3.20 | -3.58 | — | 100.00K |
| 2026-02-19 | -3.50 | -3.13 | — | 66.67K |
| 2025-11-05 | -3.36 | -3.45 | — | 256.09K |
| 2025-08-04 | -3.31 | -3.40 | — | 59.44K |
| 2025-05-02 | -3.29 | -3.20 | — | 198.80K |
| 2025-02-28 | -2.94 | -2.76 | 7.46M | 297.88K |
| 2024-11-06 | -2.75 | -2.01 | 302.00K | 365.00K |
| 2024-08-13 | -1.74 | -2.38 | 357.00K | 830.00K |
| 2024-05-13 | -2.84 | -2.01 | 431.00K | 1.62M |
| 2024-03-05 | -2.97 | -3.15 | 515.00K | 50.00K |
| 2023-11-07 | -2.70 | -5.25 | 468.00K | — |
| 2023-08-09 | -7.35 | -9.90 | 781.00K | — |
| 2023-05-11 | -10.64 | -11.24 | 683.00K | — |
| 2023-02-07 | -13.04 | -10.94 | — | — |
| 2022-11-09 | -14.39 | -13.79 | — | — |
| 2022-08-08 | -19.79 | -19.49 | — | — |
| 2022-05-09 | -22.64 | -19.34 | — | — |
| 2022-02-28 | -19.49 | -16.19 | — | — |
| 2021-11-03 | -14.99 | -13.94 | — | — |
| 2021-08-16 | -13.19 | -10.19 | — | — |
| 2021-05-11 | -10.64 | -11.09 | — | — |
| 2021-03-17 | -13.04 | -5.70 | — | — |
| 2020-11-23 | -12.10 | -0.73 | — | — |
| 2020-10-16 | -105.64 | — | — | — |
| 2020-03-31 | -76.69 | — | — | — |
| 2019-12-31 | -68.71 | — | — | — |
| 2019-09-30 | -101.99 | — | — | — |
| 2019-06-30 | -100.35 | — | — | — |
| 2019-03-31 | -100.35 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Souza Marcio | Sell | 20.52K | — | — |
| 2026-07-08 | Souza Marcio | Sell | 2.60K | — | — |
| 2026-06-24 | DeSimone Jill | Buy | 3.03K | $147.30 | 446.91K |
| 2026-06-24 | DeSimone Jill | Sell | 10 | $301.44 | 3.01K |
| 2026-06-24 | DeSimone Jill | Sell | 120 | $303.13 | 36.38K |
| 2026-06-24 | DeSimone Jill | Sell | 320 | $305.31 | 97.70K |
| 2026-06-24 | DeSimone Jill | Sell | 683 | $306.77 | 209.52K |
| 2026-06-24 | DeSimone Jill | Sell | 1.24K | $308.24 | 382.22K |
| 2026-06-24 | DeSimone Jill | Buy | 8.57K | $44.25 | 379.05K |
| 2026-06-24 | DeSimone Jill | Sell | 999 | $309.38 | 309.07K |
| 2026-06-24 | DeSimone Jill | Sell | 1.75K | $310.89 | 544.06K |
| 2026-06-24 | DeSimone Jill | Sell | 2.85K | $311.91 | 890.20K |
| 2026-06-24 | DeSimone Jill | Sell | 1.00K | $312.83 | 314.08K |
| 2026-06-24 | DeSimone Jill | Sell | 504 | $313.66 | 158.09K |
| 2026-06-24 | DeSimone Jill | Sell | 1.28K | $314.90 | 402.76K |
| 2026-06-24 | DeSimone Jill | Sell | 837 | $315.70 | 264.25K |
| 2026-06-24 | DeSimone Jill | Sell | 8.57K | $44.25 | 379.05K |
| 2026-06-24 | DeSimone Jill | Sell | 3.03K | $147.30 | 446.91K |
| 2026-06-10 | Arbuckle Stuart A | Buy | 1.37K | — | — |
| 2026-06-10 | Arbuckle Stuart A | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | Chodakewitz Jeffrey | Buy | 1.37K | — | — |
| 2026-06-10 | Chodakewitz Jeffrey | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | YOUNG WILLIAM D | Buy | 1.37K | — | — |
| 2026-06-10 | YOUNG WILLIAM D | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | DeSimone Jill | Buy | 1.37K | — | — |
| 2026-06-10 | DeSimone Jill | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | Cudkowicz Merit Ester | Buy | 1.37K | — | — |
| 2026-06-10 | Cudkowicz Merit Ester | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | MITCHELL DEAN J | Buy | 1.37K | — | — |
| 2026-06-10 | MITCHELL DEAN J | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | KINDLER JEFFREY B | Buy | 1.37K | — | — |
| 2026-06-10 | KINDLER JEFFREY B | Buy | 648 | $240.66 | 155.95K |
| 2026-06-10 | Norden Gregory | Buy | 1.37K | — | — |
| 2026-06-10 | Norden Gregory | Buy | 648 | $240.66 | 155.95K |
| 2026-05-14 | Mastrocola Lauren | Buy | 127 | $167.94 | 21.33K |
| 2026-05-14 | Nemiroff Alex | Buy | 78 | $167.94 | 13.10K |
| 2026-05-14 | Kelly Timothy Edwin | Buy | 121 | $167.94 | 20.32K |
| 2026-05-14 | Sniecinski Megan | Buy | 89 | $167.94 | 14.95K |
| 2026-05-14 | Souza Marcio | Buy | 126 | $167.94 | 21.16K |
| 2026-02-06 | Arbuckle Stuart A | Buy | 478 | — | — |
| 2026-02-06 | Arbuckle Stuart A | Buy | 688 | — | — |
| 2026-02-06 | Arbuckle Stuart A | Buy | 224 | $319.57 | 71.58K |
| 2026-02-06 | KINDLER JEFFREY B | Buy | 478 | — | — |
| 2026-02-06 | KINDLER JEFFREY B | Buy | 688 | — | — |
| 2026-02-06 | KINDLER JEFFREY B | Buy | 224 | $319.57 | 71.58K |
| 2026-01-12 | Mastrocola Lauren | Sell | 344 | $275.74 | 94.85K |
| 2026-01-12 | Sniecinski Megan | Sell | 885 | $275.74 | 244.03K |
| 2026-01-12 | Nemiroff Alex | Sell | 768 | $275.74 | 211.77K |
| 2026-01-12 | Kelly Timothy Edwin | Sell | 943 | $275.74 | 260.02K |
| 2026-01-10 | Mastrocola Lauren | Sell | 367 | $288.45 | 105.86K |
| 2026-01-10 | Sniecinski Megan | Sell | 1.09K | $288.45 | 313.55K |
| 2026-01-10 | Nemiroff Alex | Sell | 917 | $288.45 | 264.51K |
| 2026-01-10 | Kelly Timothy Edwin | Sell | 1.33K | $288.45 | 385.08K |
| 2026-01-10 | Souza Marcio | Sell | 4.25K | $288.45 | 1.23M |
| 2026-01-08 | Mastrocola Lauren | Buy | 3.75K | — | — |
| 2026-01-08 | Mastrocola Lauren | Buy | 7.50K | $294.38 | 2.21M |
| 2026-01-08 | Sniecinski Megan | Buy | 9.62K | — | — |
| 2026-01-08 | Sniecinski Megan | Buy | 7.70K | $294.38 | 2.27M |
| 2026-01-08 | Nemiroff Alex | Buy | 6.88K | — | — |
| 2026-01-08 | Nemiroff Alex | Buy | 5.50K | $294.38 | 1.62M |
| 2026-01-08 | Kelly Timothy Edwin | Buy | 8.80K | — | — |
| 2026-01-08 | Kelly Timothy Edwin | Buy | 7.04K | $294.38 | 2.07M |
| 2026-01-08 | Souza Marcio | Buy | 27.64K | — | — |
| 2026-01-08 | Souza Marcio | Buy | 22.11K | $294.38 | 6.51M |
| 2026-01-08 | Arbuckle Stuart A | Other | 0 | — | — |
| 2026-01-08 | KINDLER JEFFREY B | Other | 0 | — | — |
| 2026-01-07 | Mastrocola Lauren | Sell | 35 | $292.63 | 10.24K |
| 2026-01-07 | Nemiroff Alex | Sell | 89 | $292.63 | 26.04K |
| 2026-01-07 | Kelly Timothy Edwin | Sell | 139 | $292.63 | 40.68K |
| 2026-01-07 | Souza Marcio | Sell | 405 | $292.63 | 118.52K |
| 2026-01-01 | Sniecinski Megan | Other | 0 | — | — |
| 2026-01-01 | Sniecinski Megan | Other | 30.00K | $43.37 | 1.30M |
| 2026-01-01 | Sniecinski Megan | Other | 821 | $31.80 | 26.11K |
| 2026-01-01 | Sniecinski Megan | Other | 10.00K | $44.40 | 443.96K |
| 2026-01-01 | Sniecinski Megan | Other | 36.40K | $56.94 | 2.07M |
| 2026-01-01 | Sniecinski Megan | Other | 22.50K | $63.15 | 1.42M |
| 2026-01-01 | Sniecinski Megan | Other | 12.00K | $257.25 | 3.09M |
| 2025-12-30 | Souza Marcio | Sell | 400 | — | — |
| 2025-11-20 | Nemiroff Alex | Buy | 9.10K | $56.94 | 518.15K |
| 2025-11-20 | Nemiroff Alex | Sell | 1.71K | $190.86 | 327.14K |
| 2025-11-20 | Nemiroff Alex | Buy | 5.65K | $44.40 | 250.95K |
| 2025-11-20 | Nemiroff Alex | Buy | 2.43K | $44.40 | 108.07K |
| 2025-11-20 | Nemiroff Alex | Sell | 13.34K | $192.53 | 2.57M |
| 2025-11-20 | Nemiroff Alex | Sell | 977 | $193.23 | 188.79K |
| 2025-11-20 | Nemiroff Alex | Buy | 6.23K | $133.65 | 832.64K |
| 2025-11-20 | Nemiroff Alex | Buy | 1.71K | $83.85 | 143.72K |
| 2025-11-20 | Nemiroff Alex | Sell | 9.10K | $194.30 | 1.77M |
| 2025-11-20 | Nemiroff Alex | Sell | 9.10K | $56.94 | 518.15K |
| 2025-11-20 | Nemiroff Alex | Sell | 5.65K | $44.40 | 250.95K |
| 2025-11-20 | Nemiroff Alex | Sell | 2.43K | $44.40 | 108.07K |
| 2025-11-20 | Nemiroff Alex | Sell | 6.23K | $133.65 | 832.64K |
| 2025-11-20 | Nemiroff Alex | Sell | 1.71K | $83.85 | 143.72K |
| 2025-11-20 | Mastrocola Lauren | Buy | 5.25K | $56.94 | 298.94K |
| 2025-11-20 | Mastrocola Lauren | Buy | 2.35K | $44.40 | 104.38K |
| 2025-11-20 | Mastrocola Lauren | Buy | 207 | $44.40 | 9.19K |
| 2025-11-20 | Mastrocola Lauren | Buy | 2.68K | $43.37 | 116.23K |
| 2025-11-20 | Mastrocola Lauren | Buy | 1.56K | $133.65 | 208.09K |
| 2025-11-20 | Mastrocola Lauren | Sell | 11.46K | $191.96 | 2.20M |
| 2025-11-20 | Mastrocola Lauren | Buy | 508 | $83.85 | 42.60K |
| 2025-11-20 | Mastrocola Lauren | Buy | 1.05K | $49.50 | 51.83K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 330, holders +19 vs prior quarter. Ownership 116.55%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| JUPITER TOPCO LLC | 3.42M | 3.42M | New | 1.15B |
| FMR LLC | 2.32M | 155.96K | +7.22% | 775.68M |
| BLACKROCK, INC. | 2.29M | -32.34K | -1.39% | 767.53M |
| PERCEPTIVE ADVISORS LLC | 2.04M | 0 | 0.00% | 681.63M |
| BAKER BROS. ADVISORS LP | 1.75M | 0 | 0.00% | 586.95M |
| ORBIS ALLAN GRAY LTD | 1.53M | -942.69K | -38.13% | 512.16M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.34M | 578.44K | +76.44% | 447.01M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.24M | 13.36K | +1.09% | 413.57M |
| STATE STREET CORP | 1.03M | 142.21K | +16.08% | 343.66M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.02M | 199.74K | +24.49% | 339.97M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 963.35K | 0 | 0.00% | 322.52M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 959.05K | 9.82K | +1.03% | 321.08M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 943.00K | 312.15K | +49.48% | 315.71M |
| MORGAN STANLEY | 854.11K | 20.62K | +2.47% | 285.95M |
| GEODE CAPITAL MANAGEMENT, LLC | 748.04K | 97.14K | +14.92% | 250.48M |
| CORMORANT ASSET MANAGEMENT, LP | 640.00K | -245.50K | -27.72% | 214.27M |
| GOLDMAN SACHS GROUP INC | 548.83K | -161.90K | -22.78% | 183.74M |
| BANK OF AMERICA CORP /DE/ | 546.93K | 12.33K | +2.31% | 183.11M |
| INVESCO LTD. | 537.55K | 476.15K | +775.53% | 179.97M |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 425.17K | 66.55K | +18.56% | 142.34M |
| NORGES BANK | 346.97K | 346.97K | New | 116.16M |
| FRANKLIN TEMPLETON INC | 327.12K | 51.00K | +18.47% | 109.52M |
| PICTET ASSET MANAGEMENT HOLDING SA | 291.69K | 5.04K | +1.76% | 98.04M |
| POLAR CAPITAL HOLDINGS PLC | 279.13K | 279.13K | New | 93.45M |
| VIVO CAPITAL, LLC | 271.12K | -67.78K | -20.00% | 90.77M |
Earnings and financials
Praxis Precision Medicines, Inc. (PRAX) trades at $278.63, with a market cap of $7.78B and a trailing P/E of -20.65. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 2447000 | 8553000 | 0 |
Insights · Dividends · Forecast · Financials · Learn